首页> 外国专利> A novel cell line which produce large quantity of plasma type platelet-activating factor acetylhydrolase in a stable manner preparation thereof and a mass production of the enzyme using the cell line

A novel cell line which produce large quantity of plasma type platelet-activating factor acetylhydrolase in a stable manner preparation thereof and a mass production of the enzyme using the cell line

机译:以稳定的方式产生大量血浆型血小板活化因子乙酰水解酶的新型细胞系的制备及其使用该细胞系的酶的大量生产

摘要

PURPOSE: Provided are a novel cell line producing a large quantity of plasma type platelet-activating factor acetylhydrolase(PAF-AH) in a stable manner, a preparation method thereof and a production method of the enzyme, PAF-AH using the same. The enzyme, PAF-AH is useful for prevention and treatment of diseases mediated by PAF. CONSTITUTION: A novel cell line producing plasma type platelet-activating factor acetylhydrolase(PAF-AH) is produced by cloning bovine plasma type PAF-AH gene to an eukaryote overexpression vector pCR3.1 and transforming an animal cell with the cloned vector, wherein the bovine plasma type PAF-AH gene consists of nucleotides positioned at 757 to 2094 in the nucleotide sequence of SEQ ID NO: 3; the animal cell is HEK293; and the cell line is BGP8 (KCLRF-BP-00055). A mass production method of the PAF-AH comprises culturing the PAF-AH producing cell line BGP8 (KCLRF-BP-00055) in a medium, wherein the medium is a serum free medium or a protein free medium.
机译:目的:提供一种稳定地产生大量血浆型血小板活化因子乙酰水解酶(PAF-AH)的新型细胞系,其制备方法以及使用该细胞系的酶的制备方法。 PAF-AH酶可用于预防和治疗PAF介导的疾病。组成:一种产生血浆型血小板活化因子乙酰水解酶(PAF-AH)的新型细胞系,是通过将牛血浆型PAF-AH基因克隆到真核表达载体pCR3.1并用该克隆载体转化动物细胞而产生的,其中牛血浆型PAF-AH基因由SEQ ID NO:3的核苷酸序列中位于757至2094的核苷酸组成;动物细胞是HEK293;单元格为BGP8(KCLRF-BP-00055)。 PAF-AH的批量生产方法包括在培养基中培养产生PAF-AH的细胞系BGP8(KCLRF-BP-00055),其中所述培养基是无血清培养基或无蛋白质培养基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号